Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immuron Limited - American Depositary Shares (NQ:IMRN)

0.9801 +0.0001 (+0.01%)
Streaming Delayed Price Updated: 2:28 PM EST, Jan 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immuron Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
Immuron welcomes launch of Travelan on Amazon US
--News Direct-- 
Via News Direct
News headline image
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗
Shares of Porch Group, Inc. (NASDAQ: PRCH) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning! 
Via InvestorPlace
News headline image
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Presentation Australian Biologics Festival 2024
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron achieves record Travelan® sales
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron achieves record half yearly Travelan® sales
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Clinical Trials Update
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO Steven Lydeamore Investor Webinar Presentation
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO Steven Lydeamore presented at AusBioInvest
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Announces Travelan® Clinical Study Cohort 2 commences
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron achieves record quarterly Travelan® sales
From Immuron Limited
Via GlobeNewswire
Immuron hails record monthly sales of Travelan
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steve Lydeamore speaks with Proactive following news the company has achieved record monthly sales of its over-the-counter gastrointestinal supplement Travelan®.... 
Via TheNewswire.com
Immuron hails record monthly sales of Travelan
--News Direct-- 
Via News Direct
News headline image
Immuron achieves record monthly Travelan® sales
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron to present at the Military Health System Research Symposium
From Immuron Limited
Via GlobeNewswire
Immuron welcomes launch of Travelan on Amazon US
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) chief commercial officer Flavio Palumbo speaks with Proactive following the news its Travelan product has launched on Amazon US. 
Via TheNewswire.com
News headline image
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore to present at Bioshares
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Business Update - Ateria Health launches Juvia™ in Australia
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron FY23 Sales increase 136% on FY22 Sales
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Chairman Transition
From Immuron Limited
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.